Vaxcyte, Inc. (PCVX)
67.29
-0.24
(-0.36%)
USD |
NASDAQ |
Nov 10, 09:51
Vaxcyte Cash and Short Term Investments (Quarterly) : 1.292B for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.292B |
| June 30, 2026 | 1.487B |
| March 31, 2026 | 1.737B |
| December 31, 2025 | 1.561B |
| September 30, 2025 | 1.711B |
| June 30, 2025 | 1.661B |
| March 31, 2025 | 1.672B |
| December 31, 2024 | 1.747B |
| September 30, 2024 | 2.180B |
| June 30, 2024 | 1.453B |
| March 31, 2024 | 1.487B |
| December 31, 2023 | 1.080B |
| September 30, 2023 | 1.266B |
| June 30, 2023 | 1.287B |
| Date | Value |
|---|---|
| March 31, 2023 | 822.04M |
| December 31, 2022 | 931.38M |
| September 30, 2022 | 362.23M |
| June 30, 2022 | 354.50M |
| March 31, 2022 | 334.64M |
| December 31, 2021 | 245.97M |
| September 30, 2021 | 278.58M |
| June 30, 2021 | 292.12M |
| March 31, 2021 | 321.12M |
| December 31, 2020 | 386.20M |
| September 30, 2020 | 397.05M |
| June 30, 2020 | 410.05M |
| March 31, 2020 | 154.79M |
| December 31, 2019 | 58.98M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Moderna, Inc. | 5.171B |
| Vir Biotechnology, Inc. | 460.29M |
| Anavex Life Sciences Corp. | 118.33M |
| Revolution Medicines, Inc. | 3.651B |
| Foghorn Therapeutics, Inc. | -- |